700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
|Kevin S. Murnane|
|Kevin S. Murnane, Ph.D.
Department of Pharmaceutical Sciences
Mercer University College of Pharmacy USA
Dr. Kevin Murnane's research group is focused on the etiology, consequences, and treatment of disorders of the central nervous system. His research lab has the most well developed interests in the study of drug addiction and Alzheimer's disease. To develop new treatments for these disorders, the Murnane group uses techniques such as behavioral pharmacology, operant conditioning, neuroimaging, in vivo microdialysis, computational chemistry, analytical chemistry, drug formulation, physiology, electroencephalography, and immunohistochemistry. Dr. Murnane collaborates with other scientists within the Mercer College of Pharmacy to drive these studies, including scientists within the Center for Drug Delivery Research and the Center for Drug Design. The Murnane lab also works closely with scientists at Emory University School of Medicine in Atlanta, Mercer University School of Medicine in Macon, the University of Arkansas for Medical Sciences in Little Rock, the Research Triangle Institute in North Carolina and the Riken Brain Science Institute in Japan.
His research interests include etiology, consequences, and treatment of disorders of the central nervous system, both psychiatric and neurological disorders, behavioral pharmacology, neuropharmacology, neurotoxicology, neurochemistry, substance abuse, cognition, depression, anxiety, learning and memory, and sleep.
Global Speakers in the subject
Global Experts in the subject